Enterprise Value
$7.29 B
-$156.49 M-2.10%
Sat, 21 Dec 2024 00:31:54 GMT
Summary:
Halozyme Therapeutics enterprise value is currently $7.29 billion, with a fall of -$156.49 million (-2.10%) during the most recent trading day. Over the past year, it has increased by +$1.27 billion (+21.04%). HALO enterprise value is now -23.64% below its all-time high of $9.55 billion.HALO Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HALO Enterprise Value Performance
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| todaytoday | -2.1% | -2.6% | -2.6% |
| 1 m1 month | +0.9% | +1.1% | +1.1% |
| 3 m3 months | -17.3% | -20.8% | -21.1% |
| 6 m6 months | -7.5% | -9.2% | -9.2% |
| ytdytd | +20.2% | +26.8% | +26.4% |
| 1 y1 year | +21.0% | +23.8% | +28.5% |
| 5 y5 years | +173.2% | +123.0% | +156.9% |
HALO Enterprise Value High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | $7.71 B | -5.4% | $7.23 B | +0.9% |
| 3 m | 3 months | $9.30 B | -21.6% | $6.21 B | +17.5% |
| 6 m | 6 months | $9.55 B | -23.6% | $6.21 B | +17.5% |
| 1 y | 1 year | $9.55 B | -23.6% | $5.56 B | +31.0% |
| 3 y | 3 years | $9.55 B | -23.6% | $5.15 B | +41.5% |
| 5 y | 5 years | $9.55 B | -23.6% | $2.20 B | +231.2% |
| alltime | all time | $9.55 B | -23.6% | $51 M | >+9999.0% |
Halozyme Therapeutics Enterprise Value History
| Date | Value |
|---|---|
| 2024 | $7.29 B(+20.2%) |
| 2023 | $6.07 B(-32.2%) |
| 2022 | $8.95 B(+42.3%) |
| 2021 | $6.29 B(+4.5%) |
| 2020 | $6.02 B(+122.3%) |
| 2019 | $2.71 B(+23.8%) |
| 2018 | $2.19 B(-25.3%) |
| 2017 | $2.93 B(+104.7%) |
| 2016 | $1.43 B(-35.8%) |
| 2015 | $2.23 B(+85.4%) |
| Date | Value |
|---|---|
| 2014 | $1.20 B(-30.9%) |
| 2013 | $1.74 B(+152.8%) |
| 2012 | $687.89 M(-26.5%) |
| 2011 | $936.11 M(+31.2%) |
| 2010 | $713.34 M(+51.5%) |
| 2009 | $470.71 M(+20.0%) |
| 2008 | $392.37 M(-14.0%) |
| 2007 | $456.22 M(-10.4%) |
| 2006 | $509.14 M(+462.5%) |
| 2005 | $90.52 M(-1.9%) |
| 2004 | $92.24 M |
FAQ
- What is Halozyme Therapeutics enterprise value?
- What is the all time high enterprise value for Halozyme Therapeutics?
- What is HALO enterprise value year-to-date change?
- What is Halozyme Therapeutics enterprise value year-on-year change?
What is Halozyme Therapeutics enterprise value?
The current enterprise value of HALO is $7.29 B
What is the all time high enterprise value for Halozyme Therapeutics?
Halozyme Therapeutics all-time high enterprise value is $9.55 B
What is HALO enterprise value year-to-date change?
Halozyme Therapeutics enterprise value has changed by +$1.23 B (+20.19%) since the beginning of the year
What is Halozyme Therapeutics enterprise value year-on-year change?
Over the past year, HALO enterprise value has changed by +$1.27 B (+21.04%)